Nasopharyngeal carcinoma. Treatment planning with IMRT and 3D conformal radiotherapy

References

• Parkin, DM, Whelan, SL, Ferlay, J, Raymond, L, Young, J, editors. Cancer incidence in five continents. Volume VII. IARC Sci Publ no. 143; 1997.
   Google Scholar
• Chan AT, Theo PM, Huang DP. Pathogenesis and treatment of nasopharyngeal carcinoma. Semin Oncol 2004; 31: 794–801
   PubMedGoogle Scholar
• Chua DT, Sham JS, Kwong DL, Au GK. Treatment outcome after radiotherapy alone for patients with Stage I–II nasopharyngeal carcinoma. Cancer 2003; 98: 74–80
   PubMed Web of Science ®Google Scholar
• Langendijk JA, Leemans ChR, Buter J, Berghof J, Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: A meta-analysis of the published literature. J Clin Oncol 2004; 22: 4604–12
   PubMed Web of Science ®Google Scholar
• Emami B, Sethi A, Petruzzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003; 57: 481–8
   PubMed Web of Science ®Google Scholar
• Wu VWC, Kwong DLW, Sham JST. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol 2004; 71: 201–6
   PubMed Web of Science ®Google Scholar
• Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L, et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5–85. Radiother Oncol 1998; 46: 135–46
   PubMed Web of Science ®Google Scholar
• Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003; 69: 227–36
   PubMed Web of Science ®Google Scholar
• Wang CC. Radiation therapy for head and neck neoplasms. John Wright, Boston 1983
   Google Scholar
• Kam MKM, Chau RMC, Suen J, Choi PHK, Teo PML. Intensity-modulated radiotherapy in nasopharyngeal carcinoma. Dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 2003; 56: 145–57
   PubMedGoogle Scholar
• Knoos T, Kristensen I, Nilsson P. Volumetric and dosimetric evaluation of radiation treatment plans: Radiation conformity index. Int J Radiat Oncol Biol Phys 1998; 42: 1169–76
   PubMedGoogle Scholar
• Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000; 48: 329–37
   PubMedGoogle Scholar
• Saarilahti K, Kouri M, Collan J, Hamalainen T, Atula T, Joensuu H, et al. Intensity modulated radiotherapy for head and neck cancer: Evidence for preserved salivary gland function. Radiother Oncol 2005; 74: 251–8
   PubMed Web of Science ®Google Scholar
• Kam, MK, Leung, SF, Zee, B, Choi, PH, Chau, RM, Cheung, KY, et al. Impact of intensity-modulated radiotherapy (IMRT) on salivary function in early-stage nasopharyngeal carcinoma (NPC) patients: A prospective randomized study. Proceedings of ASCO Annual Meeting. 2005; #5501.
   Google Scholar
• Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2006; 64: 57–62
   PubMed Web of Science ®Google Scholar
• Kam MK, Teo PML, Chau RM, Cheung KY, Choi PH, Kwan WH, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience. Int J Radiat Oncol Biol Phys 2004; 60: 1440–50
   PubMed Web of Science ®Google Scholar
• Lin JC, Liang WM, Jan JS, Jiang RS, Lin AC. Another way to estimate outcome of advanced nasopharyngeal carcinoma – is concurrent chemoradiotherapy adequate?. Int J Radiat Oncol Biol Phys 2004; 60: 156–64
   PubMedGoogle Scholar